Inventor · disambiguated record
Taranjit S. Gujral
Also filed as: GUJRAL TARANJIT · GUJRAL TARANJIT S
3 granted patents·4 pending applications·36 citations·filing 2009–2023
63Inventor score
Files withGUJRAL TARANJIT S2HARVARD COLLEGE2FRED HUTCHINSON CANCER CENTER1Fred Hutchison Cancer Center1UNIV WASHINGTON1
Top patents by PatentIndex Score
7 records- 0185US8629135B2Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancerGUJRAL TARANJIT S·Filed 2009·Granted Jan 14, 2014·36 cites·39 claims
- 0259US2025166723A1Machine learning applications to predict biological outcomes and elucidate underlying biological mechanismsFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
- 0352US9260519B2Frizzled 2 as a target for therapeutic antibodies in the treatment of cancerGUJRAL TARANJIT S·Filed 2012·Granted Feb 16, 2016·0 cites·24 claims
- 0450US9765401B2Frizzled 2 as a target for therapeutic antibodies in the treatment of cancerHARVARD COLLEGE·Filed 2016·Granted Sep 19, 2017·0 cites·25 claims
- 0549US2018002754A1Frizzled 2 as a target for therapeutic antibodies in the treatment of cancerHARVARD COLLEGE·Filed 2017·Application pending·0 cites
- 0649US2023301972A1Anti-fibrotic composition and related methodsFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 0746US2021348171A1Pharmacoproteomics platform identifying kinome features regulating drug response in cancerUNIV WASHINGTON·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Taranjit S. Gujral files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →